Corpus GrippeCanadaV3

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada.

Identifieur interne : 000650 ( Main/Exploration ); précédent : 000649; suivant : 000651

Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada.

Auteurs : Danuta M. Skowronski [Canada] ; Gaston De Serres ; Natasha S. Crowcroft ; Naveed Z. Janjua ; Nicole Boulianne ; Travis S. Hottes ; Laura C. Rosella ; James A. Dickinson ; Rodica Gilca ; Pam Sethi ; Najwa Ouhoummane ; Donald J. Willison ; Isabelle Rouleau ; Martin Petric ; Kevin Fonseca ; Steven J. Drews ; Anuradha Rebbapragada ; Hugues Charest ; Marie-Eve Hamelin ; Guy Boivin ; Jennifer L. Gardy ; Yan Li ; Trijntje L. Kwindt ; David M. Patrick ; Robert C. Brunham

Source :

RBID : pubmed:20386731

Descripteurs français

English descriptors

Abstract

BACKGROUND

In late spring 2009, concern was raised in Canada that prior vaccination with the 2008-09 trivalent inactivated influenza vaccine (TIV) was associated with increased risk of pandemic influenza A (H1N1) (pH1N1) illness. Several epidemiologic investigations were conducted through the summer to assess this putative association.

METHODS AND FINDINGS

STUDIES INCLUDED

(1) test-negative case-control design based on Canada's sentinel vaccine effectiveness monitoring system in British Columbia, Alberta, Ontario, and Quebec; (2) conventional case-control design using population controls in Quebec; (3) test-negative case-control design in Ontario; and (4) prospective household transmission (cohort) study in Quebec. Logistic regression was used to estimate odds ratios for TIV effect on community- or hospital-based laboratory-confirmed seasonal or pH1N1 influenza cases compared to controls with restriction, stratification, and adjustment for covariates including combinations of age, sex, comorbidity, timeliness of medical visit, prior physician visits, and/or health care worker (HCW) status. For the prospective study risk ratios were computed. Based on the sentinel study of 672 cases and 857 controls, 2008-09 TIV was associated with statistically significant protection against seasonal influenza (odds ratio 0.44, 95% CI 0.33-0.59). In contrast, estimates from the sentinel and three other observational studies, involving a total of 1,226 laboratory-confirmed pH1N1 cases and 1,505 controls, indicated that prior receipt of 2008-09 TIV was associated with increased risk of medically attended pH1N1 illness during the spring-summer 2009, with estimated risk or odds ratios ranging from 1.4 to 2.5. Risk of pH1N1 hospitalization was not further increased among vaccinated people when comparing hospitalized to community cases.

CONCLUSIONS

Prior receipt of 2008-09 TIV was associated with increased risk of medically attended pH1N1 illness during the spring-summer 2009 in Canada. The occurrence of bias (selection, information) or confounding cannot be ruled out. Further experimental and epidemiological assessment is warranted. Possible biological mechanisms and immunoepidemiologic implications are considered.


DOI: 10.1371/journal.pmed.1000258
PubMed: 20386731


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada.</title>
<author>
<name sortKey="Skowronski, Danuta M" sort="Skowronski, Danuta M" uniqKey="Skowronski D" first="Danuta M" last="Skowronski">Danuta M. Skowronski</name>
<affiliation wicri:level="1">
<nlm:affiliation>British Columbia Centre for Disease Control (BCCDC), Vancouver, British Columbia, Canada. danuta.skowronski@bccdc.ca</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>British Columbia Centre for Disease Control (BCCDC), Vancouver, British Columbia</wicri:regionArea>
<wicri:noRegion>British Columbia</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="De Serres, Gaston" sort="De Serres, Gaston" uniqKey="De Serres G" first="Gaston" last="De Serres">Gaston De Serres</name>
</author>
<author>
<name sortKey="Crowcroft, Natasha S" sort="Crowcroft, Natasha S" uniqKey="Crowcroft N" first="Natasha S" last="Crowcroft">Natasha S. Crowcroft</name>
</author>
<author>
<name sortKey="Janjua, Naveed Z" sort="Janjua, Naveed Z" uniqKey="Janjua N" first="Naveed Z" last="Janjua">Naveed Z. Janjua</name>
</author>
<author>
<name sortKey="Boulianne, Nicole" sort="Boulianne, Nicole" uniqKey="Boulianne N" first="Nicole" last="Boulianne">Nicole Boulianne</name>
</author>
<author>
<name sortKey="Hottes, Travis S" sort="Hottes, Travis S" uniqKey="Hottes T" first="Travis S" last="Hottes">Travis S. Hottes</name>
</author>
<author>
<name sortKey="Rosella, Laura C" sort="Rosella, Laura C" uniqKey="Rosella L" first="Laura C" last="Rosella">Laura C. Rosella</name>
</author>
<author>
<name sortKey="Dickinson, James A" sort="Dickinson, James A" uniqKey="Dickinson J" first="James A" last="Dickinson">James A. Dickinson</name>
</author>
<author>
<name sortKey="Gilca, Rodica" sort="Gilca, Rodica" uniqKey="Gilca R" first="Rodica" last="Gilca">Rodica Gilca</name>
</author>
<author>
<name sortKey="Sethi, Pam" sort="Sethi, Pam" uniqKey="Sethi P" first="Pam" last="Sethi">Pam Sethi</name>
</author>
<author>
<name sortKey="Ouhoummane, Najwa" sort="Ouhoummane, Najwa" uniqKey="Ouhoummane N" first="Najwa" last="Ouhoummane">Najwa Ouhoummane</name>
</author>
<author>
<name sortKey="Willison, Donald J" sort="Willison, Donald J" uniqKey="Willison D" first="Donald J" last="Willison">Donald J. Willison</name>
</author>
<author>
<name sortKey="Rouleau, Isabelle" sort="Rouleau, Isabelle" uniqKey="Rouleau I" first="Isabelle" last="Rouleau">Isabelle Rouleau</name>
</author>
<author>
<name sortKey="Petric, Martin" sort="Petric, Martin" uniqKey="Petric M" first="Martin" last="Petric">Martin Petric</name>
</author>
<author>
<name sortKey="Fonseca, Kevin" sort="Fonseca, Kevin" uniqKey="Fonseca K" first="Kevin" last="Fonseca">Kevin Fonseca</name>
</author>
<author>
<name sortKey="Drews, Steven J" sort="Drews, Steven J" uniqKey="Drews S" first="Steven J" last="Drews">Steven J. Drews</name>
</author>
<author>
<name sortKey="Rebbapragada, Anuradha" sort="Rebbapragada, Anuradha" uniqKey="Rebbapragada A" first="Anuradha" last="Rebbapragada">Anuradha Rebbapragada</name>
</author>
<author>
<name sortKey="Charest, Hugues" sort="Charest, Hugues" uniqKey="Charest H" first="Hugues" last="Charest">Hugues Charest</name>
</author>
<author>
<name sortKey="Hamelin, Marie Eve" sort="Hamelin, Marie Eve" uniqKey="Hamelin M" first="Marie-Eve" last="Hamelin">Marie-Eve Hamelin</name>
</author>
<author>
<name sortKey="Boivin, Guy" sort="Boivin, Guy" uniqKey="Boivin G" first="Guy" last="Boivin">Guy Boivin</name>
</author>
<author>
<name sortKey="Gardy, Jennifer L" sort="Gardy, Jennifer L" uniqKey="Gardy J" first="Jennifer L" last="Gardy">Jennifer L. Gardy</name>
</author>
<author>
<name sortKey="Li, Yan" sort="Li, Yan" uniqKey="Li Y" first="Yan" last="Li">Yan Li</name>
</author>
<author>
<name sortKey="Kwindt, Trijntje L" sort="Kwindt, Trijntje L" uniqKey="Kwindt T" first="Trijntje L" last="Kwindt">Trijntje L. Kwindt</name>
</author>
<author>
<name sortKey="Patrick, David M" sort="Patrick, David M" uniqKey="Patrick D" first="David M" last="Patrick">David M. Patrick</name>
</author>
<author>
<name sortKey="Brunham, Robert C" sort="Brunham, Robert C" uniqKey="Brunham R" first="Robert C" last="Brunham">Robert C. Brunham</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="RBID">pubmed:20386731</idno>
<idno type="pmid">20386731</idno>
<idno type="doi">10.1371/journal.pmed.1000258</idno>
<idno type="wicri:Area/Main/Corpus">000652</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000652</idno>
<idno type="wicri:Area/Main/Curation">000652</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000652</idno>
<idno type="wicri:Area/Main/Exploration">000652</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada.</title>
<author>
<name sortKey="Skowronski, Danuta M" sort="Skowronski, Danuta M" uniqKey="Skowronski D" first="Danuta M" last="Skowronski">Danuta M. Skowronski</name>
<affiliation wicri:level="1">
<nlm:affiliation>British Columbia Centre for Disease Control (BCCDC), Vancouver, British Columbia, Canada. danuta.skowronski@bccdc.ca</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>British Columbia Centre for Disease Control (BCCDC), Vancouver, British Columbia</wicri:regionArea>
<wicri:noRegion>British Columbia</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="De Serres, Gaston" sort="De Serres, Gaston" uniqKey="De Serres G" first="Gaston" last="De Serres">Gaston De Serres</name>
</author>
<author>
<name sortKey="Crowcroft, Natasha S" sort="Crowcroft, Natasha S" uniqKey="Crowcroft N" first="Natasha S" last="Crowcroft">Natasha S. Crowcroft</name>
</author>
<author>
<name sortKey="Janjua, Naveed Z" sort="Janjua, Naveed Z" uniqKey="Janjua N" first="Naveed Z" last="Janjua">Naveed Z. Janjua</name>
</author>
<author>
<name sortKey="Boulianne, Nicole" sort="Boulianne, Nicole" uniqKey="Boulianne N" first="Nicole" last="Boulianne">Nicole Boulianne</name>
</author>
<author>
<name sortKey="Hottes, Travis S" sort="Hottes, Travis S" uniqKey="Hottes T" first="Travis S" last="Hottes">Travis S. Hottes</name>
</author>
<author>
<name sortKey="Rosella, Laura C" sort="Rosella, Laura C" uniqKey="Rosella L" first="Laura C" last="Rosella">Laura C. Rosella</name>
</author>
<author>
<name sortKey="Dickinson, James A" sort="Dickinson, James A" uniqKey="Dickinson J" first="James A" last="Dickinson">James A. Dickinson</name>
</author>
<author>
<name sortKey="Gilca, Rodica" sort="Gilca, Rodica" uniqKey="Gilca R" first="Rodica" last="Gilca">Rodica Gilca</name>
</author>
<author>
<name sortKey="Sethi, Pam" sort="Sethi, Pam" uniqKey="Sethi P" first="Pam" last="Sethi">Pam Sethi</name>
</author>
<author>
<name sortKey="Ouhoummane, Najwa" sort="Ouhoummane, Najwa" uniqKey="Ouhoummane N" first="Najwa" last="Ouhoummane">Najwa Ouhoummane</name>
</author>
<author>
<name sortKey="Willison, Donald J" sort="Willison, Donald J" uniqKey="Willison D" first="Donald J" last="Willison">Donald J. Willison</name>
</author>
<author>
<name sortKey="Rouleau, Isabelle" sort="Rouleau, Isabelle" uniqKey="Rouleau I" first="Isabelle" last="Rouleau">Isabelle Rouleau</name>
</author>
<author>
<name sortKey="Petric, Martin" sort="Petric, Martin" uniqKey="Petric M" first="Martin" last="Petric">Martin Petric</name>
</author>
<author>
<name sortKey="Fonseca, Kevin" sort="Fonseca, Kevin" uniqKey="Fonseca K" first="Kevin" last="Fonseca">Kevin Fonseca</name>
</author>
<author>
<name sortKey="Drews, Steven J" sort="Drews, Steven J" uniqKey="Drews S" first="Steven J" last="Drews">Steven J. Drews</name>
</author>
<author>
<name sortKey="Rebbapragada, Anuradha" sort="Rebbapragada, Anuradha" uniqKey="Rebbapragada A" first="Anuradha" last="Rebbapragada">Anuradha Rebbapragada</name>
</author>
<author>
<name sortKey="Charest, Hugues" sort="Charest, Hugues" uniqKey="Charest H" first="Hugues" last="Charest">Hugues Charest</name>
</author>
<author>
<name sortKey="Hamelin, Marie Eve" sort="Hamelin, Marie Eve" uniqKey="Hamelin M" first="Marie-Eve" last="Hamelin">Marie-Eve Hamelin</name>
</author>
<author>
<name sortKey="Boivin, Guy" sort="Boivin, Guy" uniqKey="Boivin G" first="Guy" last="Boivin">Guy Boivin</name>
</author>
<author>
<name sortKey="Gardy, Jennifer L" sort="Gardy, Jennifer L" uniqKey="Gardy J" first="Jennifer L" last="Gardy">Jennifer L. Gardy</name>
</author>
<author>
<name sortKey="Li, Yan" sort="Li, Yan" uniqKey="Li Y" first="Yan" last="Li">Yan Li</name>
</author>
<author>
<name sortKey="Kwindt, Trijntje L" sort="Kwindt, Trijntje L" uniqKey="Kwindt T" first="Trijntje L" last="Kwindt">Trijntje L. Kwindt</name>
</author>
<author>
<name sortKey="Patrick, David M" sort="Patrick, David M" uniqKey="Patrick D" first="David M" last="Patrick">David M. Patrick</name>
</author>
<author>
<name sortKey="Brunham, Robert C" sort="Brunham, Robert C" uniqKey="Brunham R" first="Robert C" last="Brunham">Robert C. Brunham</name>
</author>
</analytic>
<series>
<title level="j">PLoS medicine</title>
<idno type="eISSN">1549-1676</idno>
<imprint>
<date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Canada (epidemiology)</term>
<term>Disease Outbreaks</term>
<term>Humans</term>
<term>Influenza A Virus, H1N1 Subtype (pathogenicity)</term>
<term>Influenza Vaccines (adverse effects)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (virology)</term>
<term>Observation</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Canada (épidémiologie)</term>
<term>Flambées de maladies</term>
<term>Grippe humaine (virologie)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Humains</term>
<term>Observation</term>
<term>Sous-type H1N1 du virus de la grippe A (pathogénicité)</term>
<term>Vaccins antigrippaux (effets indésirables)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en">
<term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>Canada</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr">
<term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en">
<term>Influenza A Virus, H1N1 Subtype</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr">
<term>Sous-type H1N1 du virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Canada</term>
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Disease Outbreaks</term>
<term>Humans</term>
<term>Observation</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Flambées de maladies</term>
<term>Humains</term>
<term>Observation</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Canada</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>
<b>BACKGROUND</b>
</p>
<p>In late spring 2009, concern was raised in Canada that prior vaccination with the 2008-09 trivalent inactivated influenza vaccine (TIV) was associated with increased risk of pandemic influenza A (H1N1) (pH1N1) illness. Several epidemiologic investigations were conducted through the summer to assess this putative association.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>METHODS AND FINDINGS</b>
</p>
<p></p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>STUDIES INCLUDED</b>
</p>
<p>(1) test-negative case-control design based on Canada's sentinel vaccine effectiveness monitoring system in British Columbia, Alberta, Ontario, and Quebec; (2) conventional case-control design using population controls in Quebec; (3) test-negative case-control design in Ontario; and (4) prospective household transmission (cohort) study in Quebec. Logistic regression was used to estimate odds ratios for TIV effect on community- or hospital-based laboratory-confirmed seasonal or pH1N1 influenza cases compared to controls with restriction, stratification, and adjustment for covariates including combinations of age, sex, comorbidity, timeliness of medical visit, prior physician visits, and/or health care worker (HCW) status. For the prospective study risk ratios were computed. Based on the sentinel study of 672 cases and 857 controls, 2008-09 TIV was associated with statistically significant protection against seasonal influenza (odds ratio 0.44, 95% CI 0.33-0.59). In contrast, estimates from the sentinel and three other observational studies, involving a total of 1,226 laboratory-confirmed pH1N1 cases and 1,505 controls, indicated that prior receipt of 2008-09 TIV was associated with increased risk of medically attended pH1N1 illness during the spring-summer 2009, with estimated risk or odds ratios ranging from 1.4 to 2.5. Risk of pH1N1 hospitalization was not further increased among vaccinated people when comparing hospitalized to community cases.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>CONCLUSIONS</b>
</p>
<p>Prior receipt of 2008-09 TIV was associated with increased risk of medically attended pH1N1 illness during the spring-summer 2009 in Canada. The occurrence of bias (selection, information) or confounding cannot be ruled out. Further experimental and epidemiological assessment is warranted. Possible biological mechanisms and immunoepidemiologic implications are considered.</p>
</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">20386731</PMID>
<DateCompleted>
<Year>2010</Year>
<Month>07</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>03</Month>
<Day>05</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">1549-1676</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>7</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2010</Year>
<Month>Apr</Month>
<Day>06</Day>
</PubDate>
</JournalIssue>
<Title>PLoS medicine</Title>
<ISOAbbreviation>PLoS Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada.</ArticleTitle>
<Pagination>
<MedlinePgn>e1000258</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pmed.1000258</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In late spring 2009, concern was raised in Canada that prior vaccination with the 2008-09 trivalent inactivated influenza vaccine (TIV) was associated with increased risk of pandemic influenza A (H1N1) (pH1N1) illness. Several epidemiologic investigations were conducted through the summer to assess this putative association.</AbstractText>
<AbstractText Label="METHODS AND FINDINGS" NlmCategory="RESULTS"></AbstractText>
<AbstractText Label="STUDIES INCLUDED" NlmCategory="METHODS">(1) test-negative case-control design based on Canada's sentinel vaccine effectiveness monitoring system in British Columbia, Alberta, Ontario, and Quebec; (2) conventional case-control design using population controls in Quebec; (3) test-negative case-control design in Ontario; and (4) prospective household transmission (cohort) study in Quebec. Logistic regression was used to estimate odds ratios for TIV effect on community- or hospital-based laboratory-confirmed seasonal or pH1N1 influenza cases compared to controls with restriction, stratification, and adjustment for covariates including combinations of age, sex, comorbidity, timeliness of medical visit, prior physician visits, and/or health care worker (HCW) status. For the prospective study risk ratios were computed. Based on the sentinel study of 672 cases and 857 controls, 2008-09 TIV was associated with statistically significant protection against seasonal influenza (odds ratio 0.44, 95% CI 0.33-0.59). In contrast, estimates from the sentinel and three other observational studies, involving a total of 1,226 laboratory-confirmed pH1N1 cases and 1,505 controls, indicated that prior receipt of 2008-09 TIV was associated with increased risk of medically attended pH1N1 illness during the spring-summer 2009, with estimated risk or odds ratios ranging from 1.4 to 2.5. Risk of pH1N1 hospitalization was not further increased among vaccinated people when comparing hospitalized to community cases.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Prior receipt of 2008-09 TIV was associated with increased risk of medically attended pH1N1 illness during the spring-summer 2009 in Canada. The occurrence of bias (selection, information) or confounding cannot be ruled out. Further experimental and epidemiological assessment is warranted. Possible biological mechanisms and immunoepidemiologic implications are considered.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Skowronski</LastName>
<ForeName>Danuta M</ForeName>
<Initials>DM</Initials>
<AffiliationInfo>
<Affiliation>British Columbia Centre for Disease Control (BCCDC), Vancouver, British Columbia, Canada. danuta.skowronski@bccdc.ca</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>De Serres</LastName>
<ForeName>Gaston</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Crowcroft</LastName>
<ForeName>Natasha S</ForeName>
<Initials>NS</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Janjua</LastName>
<ForeName>Naveed Z</ForeName>
<Initials>NZ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Boulianne</LastName>
<ForeName>Nicole</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hottes</LastName>
<ForeName>Travis S</ForeName>
<Initials>TS</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rosella</LastName>
<ForeName>Laura C</ForeName>
<Initials>LC</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Dickinson</LastName>
<ForeName>James A</ForeName>
<Initials>JA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gilca</LastName>
<ForeName>Rodica</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sethi</LastName>
<ForeName>Pam</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ouhoummane</LastName>
<ForeName>Najwa</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Willison</LastName>
<ForeName>Donald J</ForeName>
<Initials>DJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rouleau</LastName>
<ForeName>Isabelle</ForeName>
<Initials>I</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Petric</LastName>
<ForeName>Martin</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fonseca</LastName>
<ForeName>Kevin</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Drews</LastName>
<ForeName>Steven J</ForeName>
<Initials>SJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rebbapragada</LastName>
<ForeName>Anuradha</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Charest</LastName>
<ForeName>Hugues</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hamelin</LastName>
<ForeName>Marie-Eve</ForeName>
<Initials>ME</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Boivin</LastName>
<ForeName>Guy</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gardy</LastName>
<ForeName>Jennifer L</ForeName>
<Initials>JL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Yan</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kwindt</LastName>
<ForeName>Trijntje L</ForeName>
<Initials>TL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Patrick</LastName>
<ForeName>David M</ForeName>
<Initials>DM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Brunham</LastName>
<ForeName>Robert C</ForeName>
<Initials>RC</Initials>
</Author>
<Author ValidYN="Y">
<CollectiveName>Canadian SAVOIR Team</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<Agency>Canadian Institutes of Health Research</Agency>
<Country>Canada</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2010</Year>
<Month>04</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>PLoS Med</MedlineTA>
<NlmUniqueID>101231360</NlmUniqueID>
<ISSNLinking>1549-1277</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>PLoS Med. 2010 Apr;7(4):e1000259</RefSource>
<PMID Version="1">20386730</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>PLoS Med. 2010 May;7(5):e1000282</RefSource>
<PMID Version="1">20520802</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName>
<QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019370" MajorTopicYN="N">Observation</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<InvestigatorList>
<Investigator ValidYN="Y">
<LastName>Skowronski</LastName>
<ForeName>Danuta M</ForeName>
<Initials>DM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Janjua</LastName>
<ForeName>Naveed Z</ForeName>
<Initials>NZ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>De Serres</LastName>
<ForeName>Gaston</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hottes</LastName>
<ForeName>Travis S</ForeName>
<Initials>TS</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Dickinson</LastName>
<ForeName>James A</ForeName>
<Initials>JA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Crowcroft</LastName>
<ForeName>Natasha S</ForeName>
<Initials>NS</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Petric</LastName>
<ForeName>Martin</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Fonseca</LastName>
<ForeName>Kevin</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Drews</LastName>
<ForeName>Steven J</ForeName>
<Initials>SJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rebbapragada</LastName>
<ForeName>Anuradha</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Charest</LastName>
<ForeName>Hugues</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kwindt</LastName>
<ForeName>Trijntje L</ForeName>
<Initials>TL</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gardy</LastName>
<ForeName>Jennifer</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mak</LastName>
<ForeName>Annie</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Chan</LastName>
<ForeName>Tracy</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Tang</LastName>
<ForeName>Patrick</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Winter</LastName>
<ForeName>Anne-Luise</ForeName>
<Initials>AL</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Douville-Fradet</LastName>
<ForeName>Monique</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bontovics</LastName>
<ForeName>Erika</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bolotin</LastName>
<ForeName>Shelly</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Patrick</LastName>
<ForeName>David M</ForeName>
<Initials>DM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Brunham</LastName>
<ForeName>Robert C</ForeName>
<Initials>RC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gubbay</LastName>
<ForeName>Jonathan B</ForeName>
<Initials>JB</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bastien</LastName>
<ForeName>Nathalie</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Yan</ForeName>
<Initials>Y</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>De Serres</LastName>
<ForeName>Gaston</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Boulianne</LastName>
<ForeName>Nicole</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gilca</LastName>
<ForeName>Rodica</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ouhoummane</LastName>
<ForeName>Najwa</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Boivin</LastName>
<ForeName>Guy</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Fortin</LastName>
<ForeName>Elise</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Douville-Fradet</LastName>
<ForeName>Monique</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Landry</LastName>
<ForeName>Monique</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Crowcroft</LastName>
<ForeName>Natasha S</ForeName>
<Initials>NS</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Janjua</LastName>
<ForeName>Naveed Z</ForeName>
<Initials>NZ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Skowronski</LastName>
<ForeName>Danuta M</ForeName>
<Initials>DM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Crowcroft</LastName>
<ForeName>Natasha S</ForeName>
<Initials>NS</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rosella</LastName>
<ForeName>Laura C</ForeName>
<Initials>LC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sethi</LastName>
<ForeName>Pam</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Willison</LastName>
<ForeName>Donald J</ForeName>
<Initials>DJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Johnson</LastName>
<ForeName>Ian</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>McGeer</LastName>
<ForeName>Allison</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Allison</LastName>
<ForeName>Jeffrey C</ForeName>
<Initials>JC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Savage</LastName>
<ForeName>Rachel</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>De Serres</LastName>
<ForeName>Gaston</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Janjua</LastName>
<ForeName>Naveed Z</ForeName>
<Initials>NZ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Skowronski</LastName>
<ForeName>Danuta M</ForeName>
<Initials>DM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>De Serres</LastName>
<ForeName>Gaston</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Boulianne</LastName>
<ForeName>Nicole</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rouleau</LastName>
<ForeName>Isabelle</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Charest</LastName>
<ForeName>Hugues</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hamelin</LastName>
<ForeName>Marie-Eve</ForeName>
<Initials>ME</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Boivin</LastName>
<ForeName>Guy</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Quach</LastName>
<ForeName>Caroline</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Flamand</LastName>
<ForeName>Louis</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Couillard</LastName>
<ForeName>Michel</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bourgault</LastName>
<ForeName>Anne-Marie</ForeName>
<Initials>AM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Skowronski</LastName>
<ForeName>Danuta M</ForeName>
<Initials>DM</Initials>
</Investigator>
</InvestigatorList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2009</Year>
<Month>11</Month>
<Day>02</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2010</Year>
<Month>03</Month>
<Day>01</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2010</Year>
<Month>4</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2010</Year>
<Month>4</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2010</Year>
<Month>7</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">20386731</ArticleId>
<ArticleId IdType="doi">10.1371/journal.pmed.1000258</ArticleId>
<ArticleId IdType="pmc">PMC2850386</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2009 Aug 13;361(7):674-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19564633</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vet Microbiol. 2008 Jan 25;126(4):310-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17719188</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2009 Aug 20;460(7258):1021-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19672242</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2009 Aug 13;361(7):680-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19564631</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Microbes Infect. 2009 Apr;11(4):443-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19399964</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2009 Dec 15;49(12):1801-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19911946</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Virol. 1990 Apr;30(4):258-65</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2370521</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Bull World Health Organ. 1985;63(6):1055-68</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3879673</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2009 Sep 1;183(5):3294-301</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19648276</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1988 Jan;62(1):20-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3334744</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Rev Med Virol. 2003 Nov-Dec;13(6):387-98</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14625886</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Euro Surveill. 2009 Aug 06;14(31):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19660248</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMJ. 2009 Oct 06;339:b3928</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19808768</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MMWR Morb Mortal Wkly Rep. 2009 May 22;58(19):521-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19478718</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2009 Jan 15;199(2):168-79</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19086914</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Virol. 1992 Mar;36(3):217-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1564451</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Can Commun Dis Rep. 2005 Sep 15;31(18):181-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16669132</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Epidemiol. 1990 Mar;19(1):205-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2190942</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2010 Mar 6;375(9717):801-2; author reply 802-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20206765</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Infect Dis. 2009 Dec;9(12):784-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19879807</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2009 Dec 19;374(9707):2072-2079</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19913290</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Bull World Health Organ. 2005 Apr;83(4):308-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15868023</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2009 Nov 12;361(20):1945-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19745214</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Wkly Epidemiol Rec. 2010 Mar 5;85(10):81-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20210260</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMJ. 2009 Nov 24;339:b4972</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19934198</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2009 Dec 15;49(12):1811-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19911964</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20365-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19918065</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Can Commun Dis Rep. 2008 Jul;34(ACS-3):1-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18802991</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2007 Apr 12;25(15):2842-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17081662</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Epidemiol. 2006 Apr;35(2):337-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16368725</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 1976 Jan 17;1(7951):105-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">54631</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 1994 Jan;169(1):200-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8277183</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2009;4(5):e5538</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19440239</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 1966 Aug;97(2):177-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">5921310</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Epidemiol Community Health. 2002 Dec;56(12):951-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12461118</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2010 Apr 1;201(7):1000-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20170374</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MMWR Morb Mortal Wkly Rep. 2009 Nov 13;58(44):1241-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19910912</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Exp Med. 1966 Sep 1;124(3):331-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">5922742</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MMWR Morb Mortal Wkly Rep. 2009 Apr 24;58(15):400-2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19390508</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2004 Dec;10(12 Suppl):S82-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15577936</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Exp Med. 1966 Sep 1;124(3):347-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">5926092</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2010 Nov 1;51(9):1017-27</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20887210</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vet Immunol Immunopathol. 2006 Aug 15;112(3-4):117-28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16621020</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Epidemiol. 2006 Apr;35(2):345-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16368724</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Boivin, Guy" sort="Boivin, Guy" uniqKey="Boivin G" first="Guy" last="Boivin">Guy Boivin</name>
<name sortKey="Boulianne, Nicole" sort="Boulianne, Nicole" uniqKey="Boulianne N" first="Nicole" last="Boulianne">Nicole Boulianne</name>
<name sortKey="Brunham, Robert C" sort="Brunham, Robert C" uniqKey="Brunham R" first="Robert C" last="Brunham">Robert C. Brunham</name>
<name sortKey="Charest, Hugues" sort="Charest, Hugues" uniqKey="Charest H" first="Hugues" last="Charest">Hugues Charest</name>
<name sortKey="Crowcroft, Natasha S" sort="Crowcroft, Natasha S" uniqKey="Crowcroft N" first="Natasha S" last="Crowcroft">Natasha S. Crowcroft</name>
<name sortKey="De Serres, Gaston" sort="De Serres, Gaston" uniqKey="De Serres G" first="Gaston" last="De Serres">Gaston De Serres</name>
<name sortKey="Dickinson, James A" sort="Dickinson, James A" uniqKey="Dickinson J" first="James A" last="Dickinson">James A. Dickinson</name>
<name sortKey="Drews, Steven J" sort="Drews, Steven J" uniqKey="Drews S" first="Steven J" last="Drews">Steven J. Drews</name>
<name sortKey="Fonseca, Kevin" sort="Fonseca, Kevin" uniqKey="Fonseca K" first="Kevin" last="Fonseca">Kevin Fonseca</name>
<name sortKey="Gardy, Jennifer L" sort="Gardy, Jennifer L" uniqKey="Gardy J" first="Jennifer L" last="Gardy">Jennifer L. Gardy</name>
<name sortKey="Gilca, Rodica" sort="Gilca, Rodica" uniqKey="Gilca R" first="Rodica" last="Gilca">Rodica Gilca</name>
<name sortKey="Hamelin, Marie Eve" sort="Hamelin, Marie Eve" uniqKey="Hamelin M" first="Marie-Eve" last="Hamelin">Marie-Eve Hamelin</name>
<name sortKey="Hottes, Travis S" sort="Hottes, Travis S" uniqKey="Hottes T" first="Travis S" last="Hottes">Travis S. Hottes</name>
<name sortKey="Janjua, Naveed Z" sort="Janjua, Naveed Z" uniqKey="Janjua N" first="Naveed Z" last="Janjua">Naveed Z. Janjua</name>
<name sortKey="Kwindt, Trijntje L" sort="Kwindt, Trijntje L" uniqKey="Kwindt T" first="Trijntje L" last="Kwindt">Trijntje L. Kwindt</name>
<name sortKey="Li, Yan" sort="Li, Yan" uniqKey="Li Y" first="Yan" last="Li">Yan Li</name>
<name sortKey="Ouhoummane, Najwa" sort="Ouhoummane, Najwa" uniqKey="Ouhoummane N" first="Najwa" last="Ouhoummane">Najwa Ouhoummane</name>
<name sortKey="Patrick, David M" sort="Patrick, David M" uniqKey="Patrick D" first="David M" last="Patrick">David M. Patrick</name>
<name sortKey="Petric, Martin" sort="Petric, Martin" uniqKey="Petric M" first="Martin" last="Petric">Martin Petric</name>
<name sortKey="Rebbapragada, Anuradha" sort="Rebbapragada, Anuradha" uniqKey="Rebbapragada A" first="Anuradha" last="Rebbapragada">Anuradha Rebbapragada</name>
<name sortKey="Rosella, Laura C" sort="Rosella, Laura C" uniqKey="Rosella L" first="Laura C" last="Rosella">Laura C. Rosella</name>
<name sortKey="Rouleau, Isabelle" sort="Rouleau, Isabelle" uniqKey="Rouleau I" first="Isabelle" last="Rouleau">Isabelle Rouleau</name>
<name sortKey="Sethi, Pam" sort="Sethi, Pam" uniqKey="Sethi P" first="Pam" last="Sethi">Pam Sethi</name>
<name sortKey="Willison, Donald J" sort="Willison, Donald J" uniqKey="Willison D" first="Donald J" last="Willison">Donald J. Willison</name>
</noCountry>
<country name="Canada">
<noRegion>
<name sortKey="Skowronski, Danuta M" sort="Skowronski, Danuta M" uniqKey="Skowronski D" first="Danuta M" last="Skowronski">Danuta M. Skowronski</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeCanadaV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000650 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000650 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    GrippeCanadaV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:20386731
   |texte=   Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:20386731" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeCanadaV3 

Wicri

This area was generated with Dilib version V0.6.35.
Data generation: Tue Jul 7 13:36:58 2020. Site generation: Sat Sep 26 07:06:42 2020